CRYO-CELL International Q3 GAAP EPS of $0.16 Beats Estimates

Seeking Alpha··US·Read original
2▲1 ▼0Impact / 5
Summary · why it matters

CRYO-CELL International reported fiscal third-quarter 2026 GAAP earnings per share of $0.16, beating estimates by $0.13. Revenue came in at $7.82 million, down 0.1% year over year, but still ahead of expectations by $0.37 million. Shares of the cord blood banking company rose 4.56% following the release. The results were announced in a company press release.

Impact on assets 1

Biotech & Genomic Medicine▲
CryoCell International Inc
CCEL
▲ PositiveCapitalrelevance

Q3 GAAP EPS of $0.16 beat estimates by $0.13 and revenue topped expectations, driving shares up 4.56%.